Ketamine effective for treatment-resistant depression: Clinical trial
A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.
Jul 13, 2023
0
1
A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.
Jul 13, 2023
0
1
As of July 1, authorized psychiatrists have been allowed to prescribe MDMA (the chemical found in "ecstasy") to treat post-traumatic stress disorder (PTSD), and psilocybin (found in "magic mushrooms") to treat depression ...
Jul 5, 2023
0
2
A new drug, investigated by Amsterdam University Medical Centers together with colleagues around the world, is effective as a treatment against ulcerative colitis. With the clinical trial demonstrating a doubling in the rates ...
Jun 28, 2023
0
32
Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation in older men and women, according to a new study from the University of Eastern Finland.
Jun 27, 2023
0
24
Evidence from a small-scale clinical trial suggests that a variation of the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, an autoimmune disorder of the nervous system. The ...
Jun 22, 2023
0
51
Could a dose of hookworms provide a medication-free alternative to people with inflammatory bowel disease? The Malaghan Institute's Hookworm Therapy team, who recently published the results from their year-long clinical study, ...
Jun 16, 2023
0
121
The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.
Jun 15, 2023
0
1
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
2
People who took a cheap diabetes drug after testing positive for COVID-19 had a 40 percent lower risk of getting long COVID, a US-based study said Friday.
Jun 11, 2023
0
42
For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published online June ...
Jun 8, 2023
0
15